Programmed Cell Death in Normal Epidermis and Loricrin Keratoderma. Multiple Functions of Profilaggrin in Keratinization  by Ishida-Yamamoto, Akemi et al.
Programmed Cell Death in Normal Epidermis and Loricrin
Keratoderma. Multiple Functions of Profilaggrin in
Keratinization
Akemi Ishida-Yamamoto, Hikaru Tanaka, Hiroshi Nakane, Hidetoshi Takahashi, Yoshio Hashimoto, and
Hajime Iizuka
Department of Dermatology, Asahikawa Medical College, Asahikawa, Japan
The terminal differentiation of epidermal keratinocytes
has been regarded as an example of programmed cell
death. Among the proteins specifically expressed in this
process is profilaggrin, which consists of filaggrin repeats
and N- and C-terminal domains. Profilaggrin is proteo-
lytically processed into individual domains during the
terminal differentiation. Filaggrin released from profil-
aggrin aggregates keratin filaments to form compacted
cornified cells with a keratin pattern. A recent transfection
experiment has indicated initiation of cell death by
filaggrin expression constructs. The transitional cells
between the granular and cornified cells show morpho-
logic characteristics of apoptotic cells, and their nuclei
contain fragmented DNA and profilaggrin N-terminal
The terminal differentiation of epidermal keratinocytes isa tightly regulated process, the molecular mechanismsof which are not fully understood. The process has longbeen suggested to be a form of programmed cell death.If so, the mechanisms of abnormal keratinization might
be explained in terms of alteration of cell-death program. In this review
we have chosen loricrin keratoderma, a genetic skin disease caused by
loricrin mutations, as an example of the diseases where keratinization
is specifically disrupted, and discussed how the mutant loricrin could
possibly disrupt terminal differentiation. In this regard, special reference
will be made to unique functions of the N-terminal domains of
profilaggrin in epidermal keratinization.
KERATINIZATION AS PROGRAMMED CELL DEATH
Epidermal keratinocytes are destined to be enucleated and lose their
metabolic activity as a part of their differentiation program or keratiniz-
ation. As basal cells leave the basal compartment, they move upwards
following the differentiation pathways. The final step from granular cells
through transitional cells to cornified cells involves drastic morphologic
changes and is called terminal differentiation (Holbrook, 1989; Fuchs,
1990; Roop, 1995; Eckert et al, 1997) (Fig 1a). The nucleus,
keratohyalin granules, and most other cellular organelles disappear
during this process. Keratin filaments are compacted in the cytoplasm
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domains. This suggests that the N-terminus of profil-
aggrin may participate in nuclear events accompanying
programmed cell death. Among inherited skin disorders
with abnormal keratinization, progressive symmetric
erythrokeratoderma is caused by loricrin mutation
(loricrin keratoderma). In this disease, profilaggrin N-
terminal domains are aggregated with mutant loricrin
within condensed nuclei. These nuclei persist in the
cornified layer as parakeratosis. Loricrin keratoderma
could therefore be regarded as a representative form of
disrupted cell death. Key words: apoptosis/transitional cells.
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with a keratin pattern and cell envelopes are formed underneath the
plasma membrane. Fully differentiated cells are eventually shed from
the skin surface. This process involves tightly controlled expression as
well as postsynthetic modification of a number of structural proteins,
including profilaggrin and loricrin. It also involves expression and
activation of various enzymes, including transglutaminases, kinases,
phosphatases, and proteases.
Programmed cell death occurs in various circumstances; these include
embryonic development and tissue remodeling, as well as normal tissue
turnover (Wyllie et al, 1980; Steller, 1995). Keratinization, the typical
tissue turnover process, has been regarded as programmed cell death
(Fesus et al, 1991; McCall and Cohen, 1991; Haake and Polakowska,
1993; Polakowska et al, 1994). Several lines of evidence support this
notion. A DNA ladder is detected in the differentiated epidermal layer
of newborn mice (McCall and Cohen, 1991) and in situ nick end
labeling stains differentiated human epidermal cells (Gavrieli et al, 1992;
Polakowska et al, 1994) (Fig 2a). Both techniques are widely used to
detect programmed cell death. Bcl-2, an antiapoptotic protein, is
expressed exclusively in the basal cells (Hockenbery et al, 1991),
whereas Bak, a death agonist protein, is strongly expressed in
differentiated epidermal cells (Krajewski et al, 1996). Expression of
bcl-2 antisense RNA decreases endogenous levels of Bcl-2 and induces
differentiation in a mouse keratinocyte cell line (Marthinuss et al,
1995). Caspases, a family of cystein proteases that are crucial components
of the apoptotic cell-death pathway in various systems (Nicholson and
Thornberry, 1997), are detected in keratinocytes (Krajewska et al,
1997; Takahashi et al, 1997, 1998). Sulfur mustard, an alkylating agent,
causes differentiation of keratinocytes that is accompanied by reduction
of Bcl-2 and activation of caspase-3 (Rosenthal et al, 1998). Transitional
cells show various morphologic features of apoptotic cells such as
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Figure 1. Nuclear changes in epidermal terminal differentiation. Electron
microscopy of normal skin (a) and loricrin keratoderma (b, c). (a) Note
condensed and marginated chromatin (arrows) in a transitional cell (T). (b) Many
small intranuclear granules are seen (arrowheads). (c) A parakeratotic cornified
cell contains condensed nuclear chromatin. G, granular cells. Nu, nucleus. Scale
bar: 1 µm.
Figure 2. In situ nick end labeling. Only a few cells beneath the cornified
layer are positive (arrowheads) in normal skin (a), whereas the cornified cells
contain many positive nuclei in loricrin keratoderma (b). Scale bar: 50 µm.
Figure 3. Structure of profilaggrin.
condensation of the cytoplasm and nuclear chromatin, and formation
of a cross-linked protein scaffold as cornified cell envelopes (Fig 1a)
(Brody, 1960; Kerr et al, 1972; Fesus et al, 1989). The transitional cell
nuclei indeed contain fragmented DNA, a characteristic finding of
apoptotic cells (Ishida-Yamamoto et al, 1998b).
The question is when keratinocytes are committed to undergo
programmed cell death. Cell death can be induced by disruption
of the interaction between normal epithelial cells and extracellular
matrix (Frisch and Francis, 1994; Ruoslahti and Reed, 1994), and
this phenomenon is called ‘‘anoikis’’ (Frisch and Francis, 1994).
Keratinocytes can be induced to differentiate by placing them in a
suspension culture (Green, 1977), where the addition of an extracellular
matrix protein, fibronectin, prevents the differentiation (Adams and
Watt, 1989). It seems therefore that the irreversible process of anoikis is
initiated when epidermal keratinocytes have left the basal compartments,
although the typical apoptotic morphology might not be observed
until the cells reach the transitional layer. Downregulation of β1
integrins that mediate keratinocyte adhesion to the extracellular matrix
may be one of the first steps in the cell-death program (Watt and
Hertle, 1994).
SYNTHESIS AND PROCESSING OF PROFILAGGRIN
Profilaggrin is a large (.400 kDa in human), insoluble, and highly
phosphorylated protein that consists of multiple (10–12 in humans)
filaggrin repeats flanked by N- and C-terminal domains (reviewed in
Dale et al, 1994; Manabe et al, 1997) (Fig 3). Each filaggrin domain
(38 kDa composed of 317 amino acids in humans) is linked together
with a short linker peptide. The N-terminal domain is subdivided into
the A domain, which contains S100-like calcium binding domains,
and the B domain of unknown function. Phosphorylation occurs at
multiple serine/threonine residues in each filaggrin repeat by several
kinases including casein kinase II (Dale et al, 1994; Resing et al, 1995a).
Profilaggrin is synthesized in the granular cell layer of the epidermis
and localized in keratohyalin granules. Keratohyalin granules that
contain profilaggrin are called F-granules, to distinguish them from
L-granules containing loricrin (Steven et al, 1990) (see below).
During terminal differentiation, profilaggrin is dephosphorylated
and proteolytically processed into filaggrin monomers and terminal
domains (Resing et al, 1989; Kam et al, 1993; Resing et al, 1995b;
Presland et al, 1997; Yamazaki et al, 1997). Dephosphorylation is
catalyzed by profilaggrin phosphatase, a member of the phosphatase
2A family, and at least one other phosphatase (Kam et al, 1993). At
least two endoproteinases and at least two exopeptidases are involved
in removal of linker peptides (Resing et al, 1995b). Profilaggrin
endoproteinase 1 purified from mouse epidermis is a chymotrypsin-
like serine proteinase that cleaves the linker region of mouse profilaggrin
(Resing et al, 1995b). The second endoproteinase is a leupeptin-
sensitive, calpain-like cysteine proteinase (Resing et al, 1993), and this
could be µ-calpain, an isoform of calpain that is activated at a
micromolar level of calcium (Yamazaki et al, 1997). The N-terminal
domain is cleaved by profilaggrin endoproteinase 1 (Resing et al,
1995b; Presland et al, 1997). Furin, a member of the precursor
convertase family of Ca21-dependent serine endoproteinases, also
cleaves the N-terminal profilaggrin fragments.1 The N-terminus is
further divided into A- and B-subdomains (Presland et al, 1997). As
described in the following section, filaggrin is aggregated with keratin
filaments in the cornified cells and this is followed by conversion of
basic arginine residues of filaggrin to citrullines by peptidylarginine
1Dale BA, Nirunsuksiri W, Rehemtulla A, Lewis SP, Presland RB. Profilaggrin
is proteolytically cleaved by furin during epidermal differentiation. J Invest
Dermatol 108:554, 1997 (abstr.)
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deiminase (Senshu et al, 1996). This results in a lower affinity of
filaggrin for keratin. Filaggrin is then eventually hydrolyzed into free
amino acids, possibly by cathepsin L-like proteinase (Kawada et al,
1995a) and epidermal chathepsin B (Kawada et al, 1995b).
MULTIPLE FUNCTIONS OF PROFILAGGRIN
Filaggrin functions as an intermediate filament-associated protein that
aggregates keratin filaments in cornified cells (Dale et al, 1978). Ionic
interaction between basic residues of filaggrin and the negatively
charged α-helical rod domain of keratin is suggested to be responsible
for this reaction (the ionic zipper hypothesis) (Mack et al, 1993).
Filaggrin is a minor component of the cornified cell envelopes (Steinert
and Marekov, 1995). Profilaggrin linker peptides might be cross-linked
to the cornified cell envelopes as well (Takahashi et al, 1996). Filaggrin
is degradated in the upper stratum corneum and the degradation
products have a protective effect against UV light and a water-holding
capacity (Scott et al, 1982). Recently, it was shown that transient
expression of filaggrin in cultured cells collapsed keratin filament
networks (Dale et al, 1997). The cells expressing filaggrin also displayed
disruption of the nucleus and the nuclear envelopes, and the cells
became round, lost attachment to the substratum, and died. This
suggests that filaggrin may trigger cellular events associated with
programmed cell death.
We have recently identified a distinct distribution pattern of the
N-terminal domain of profilaggrin in transitional cells (Ishida-
Yamamoto et al, 1998b). These domains were colocalized with filaggrin
domains in the keratohyalin granules of granular cells (Presland et al,
1997; Ishida-Yamamoto et al, 1998b). Only in the transitional cells
were the A and B domains of the N-terminus translocated into the
nuclei. In the cornified cells, immunoreaction to the N-terminus was
detected both in the cytoplasm and at the cell periphery (Presland et al,
1997). The mechanism for this nuclear translocation of the N-terminal
domain is not clear at this moment: this domain does not contain a
classical nuclear localization sequence and our preliminary transfection
experiments did not detect nuclear targeting by the N-terminal
profilaggrin expression constructs. The basic nature of the N-terminus
(pI 5 9.9) might result in nonspecific binding to nucleic acids.
We have also demonstrated colocalization of fragmented DNA and
profilaggrin N-terminal domains in the condensed chromatin of
transitional cells (Ishida-Yamamoto et al, 1998b). This colocalization
occurs in the level of the epidermis where DNase activity has been
detected (Steigleder and Raab, 1962). It is tempting to speculate that
the profilaggrin N-terminus plays an essential role for the nuclear
disintegration. In this context it is interesting to note that the A
domain contains two calcium-binding motifs (Presland et al, 1992;
Markova et al, 1993; Presland et al, 1995), because calcium signals are
closely associated with programmed cell death including terminal
differentiation of keratinocytes (Cohen and Duke, 1984; McCall and
Cohen, 1991).
LORICRIN AND LORICRIN KERATODERMA
Loricrin, a glycine-, serine-, and cysteine-rich, highly insoluble basic
protein, is another differentiation marker of the epidermis (Mehrel
et al, 1990; Hohl et al, 1991; Yoneda et al, 1992; Ishida-Yamamoto
et al, 1998a) (Fig 4). Human loricrin is 26 kDa and contains 315
amino acid residues. Loricrin contains repeats of a unique, highly
flexible structure called the glycine loop. Three glycine-loop domains
are interrupted by glutamine-rich domains. The N- and C-termini of
the loricrin molecule are rich in glutamine and lysine.
Loricrin is synthesized in the superficial granular layer and
accumulates in L-granules in newborn mouse epidermis (Steven et al,
1990). It is distributed diffusely within the superficial granular cells in
adult human epidermis, except foreskin and acrosyringium where
L-granules are frequently observed (Ishida-Yamamoto et al, 1993,
1996). In the cornified cells, loricrin is cross-linked into cornified cell
envelopes by transglutaminases.
Loricrin keratoderma is a group of autosomal dominantly inherited
skin diseases caused by mutations of loricrin (Ishida-Yamamoto and
Iizuka, 1998; Ishida-Yamamoto et al, 1998a). These include an
Figure 4. Loricrin and the sites of insertion mutations in loricrin
keratoderma.
ichthyotic variant of Vohwinkel’s syndrome (VS-I) and a variant of
progressive symmetric erythrokeratoderma with palmoplantar hyper-
keratosis (PSEK-V) (Maestrini et al, 1996; Ishida-Yamamoto et al, 1997;
Korge et al, 1997; Armstrong et al, 1998; Takahashi et al, 1999). These
patients carry a heterozygous insertion mutation of the loricrin gene
(Fig 4). A consequence is a frameshift that alters the carboxyl
terminus into missense sequences rich in arginine, making the mutated
loricrin more basic in nature. The patients show palmoplantar hyper-
keratosis with digital constriction in both VS-I and PSEK-V, and
generalized ichthyosis in VS-I or erythematous keratotic plaques in
PSEK-V. Histopathologic abnormalities are almost identical in VS-I
and PSEK-V (Fig 1b, c); these include thickening of the granular
layer, the presence of abnormal nuclear granules containing loricrin,
parakeratotic hyperkeratosis, and abnormal cornified cell envelopes. It
remains unknown, however, how the mutant loricrin causes these
distinct phenotypes. Because loricrin-knockout mice showed transient
erythroderma but not hyperkeratosis,2 decreased expression of wild-
type loricrin cannot explain the pathogenesis of loricrin keratoderma.
The loricrin mutation must have a dominant negative effect on the
normal keratinization process.
DISRUPTED KERATINIZATION IN LORICRIN
KERATODERMA
If programmed cell death or differentiation of keratinocytes is hampered
at a certain stage, the final process of terminal differentiation, i.e.,
sloughing of the dead horny cells from the skin surface (Kerr et al,
1972), might be affected. Cornified cells remain adherent to each
other, forming large masses that are clinically apparent as scales or
hyperkeratosis. Mutant loricrin seems to have such an effect. In PSEK-
V, loricrin aggregates were surrounded by N-terminal domains of
profilaggrin and nuclear chromatin with fragmented DNA and this
was persistently observed in the nuclei up to the superficial stratum
corneum (Ishida-Yamamoto et al, 1998b) (Fig 2b). Epidermal
differentiation appears to be disrupted at the very late stage when the
profilaggrin N-terminus is translocated into the nuclei.
CONCLUSION
Although considerable information has been obtained about gene
defects for various inherited keratinization disorders (Ishida-Yamamoto
et al, 1998c), it is not fully understood how the expression of gene
defects is related to clinical and histopathologic phenotypes distinct for
many of the diseases. Impaired cell-death in loricrin keratoderma could
be explained by a dominant negative effect of mutant loricrin against
the profilaggrin N-terminus within apoptotic nuclei, and this is
schematically drawn in Fig 5. Because an enormous amount of
information about the molecular mechanisms of programmed cell
death has been accumulating, further analysis of the pathogenesis of
2de Viragh PA, Scharer L, Bundman D, Roop DR: Loricrin deficient mice:
upregulation of other cell envelope precursors rescues the neonatal defect but
fails to restore epidermal barrier function. J Invest Dermatol 108:555, 1997 (abstr.)
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Figure 5. Keratinization in normal and loricrin keratoderma. (a) Normal;
(b) loricrin keratoderma. Nu, nucleus; C, cornified layer; T, transitional layer;
G, granular layer. Distribution of normal (hatched circle) and mutant (closed
circle) loricrin and N-terminus of profilaggrin (square) is shown.
keratinization disorders from this perspective may provide better
understanding of the keratinization process as well as new therapeutic
regimens for such disorders.
Our original studies cited here were supported in part by Grants-in-Aid for Scientific
Research from the Ministry of Education, Science, Sports and Culture of Japan to AIY
(10470184), HT (08770618), and HI (08457233), a grant from the Ministry of
Health and Welfare, Japan to HI, and a grant from Shiseido Co. to AI-Y.
REFERENCES
Adams JC, Watt FM: Fibronectin inhibits the terminal differentiatin of human keratinocytes.
Nature 340:307–309, 1989
Armstrong DKB, McKenna KE, Hughes AE: A novel insertional mutation in loricrin in
Vohwinkel’s keratoderma. J Invest Dermatol 111:702–704, 1998
Brody I: The ultrastructure of the tonofibrils in the keratinization process of normal human
epidermis. J Ultrastr Res 4:264–297, 1960
Cohen JJ, Duke RC: Glucocorticoid activation of a calcium-dependent endonuclease in
thymocyte nuclei leads to cell death. J Immunol 132:38–42, 1984
Dale BA, Holbrook KA, Steinert PM: Assembly of stratum corneum basic protein and
keratin filaments in macrofibrils. Nature 276:729–731, 1978
Dale BA, Resing KA, Presland RB. Keratohyalin granule proteins. In: Leigh I, Lane B,
Watt F (eds). The Keratinocyte Handbook. Cambridge: Cambridge University Press,
1994, pp. 323–350
Dale BA, Presland RB, Lewis SP, Underwood RA, Fleckman P: Transient expression of
epidermal filaggrin in cultured cells causes collapse of intermediate filament networks
with alteration of cell shape and nuclear integrity. J Invest Dermatol 108:179–187, 1997
Eckert RL, Crish JF, Robinson NA: The epidermal keratinocyte as a model for the study
of gene regulation and cell differentiation. Physiol Rev 77:397–424, 1997
Fesus L, Thomazy V, Autuori F, Ceru MP, Tarcsa E, Piacentini M: Apoptotic hepatocytes
become insoluble in detergents and chaotropic agents as a result of transglutaminase
action. FEBS Lett 245:150–154, 1989
Fesus L, Davies PJA, Piacentini M: Apoptosis: molecular mechanisms in programmed cell
death. Eur J Cell Biol 56:170–177, 1991
Frisch SM, Francis H: Disruption of epithelial cell–matrix interactions induces apoptosis.
J Cell Biol 124:619–626, 1994
Fuchs E: Epidermal differentiation: the bare essentials. J Cell Biol 111:2807–2814, 1990
Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ
via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493–501, 1992
Green H: Terminal differentiation of cultured human epidermal cells. Cell 11:405–416, 1977
Haake AR, Polakowska RR: Cell death by apoptosis in epidermal biology. J Invest Dermatol
101:107–112, 1993
Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: BCL2 protein is
topographically restricted in tissues characterized by apoptotic cell death. Proc Natl
Acad Sci USA 88:6961–6965, 1991
Hohl D, Mehrel T, Lichti U, Turner ML, Roop DR, Steinert PM: Characterization of
human loricrin. Structure and function of a new class of epidermal cell envelope
proteins. J Biol Chem 266:6626–6636, 1991
Holbrook KA: Biologic structure and function: perspectives on morphologic approaches
to the study of the granular layer keratinocyte. J Invest Dermatol 92:84S–104S, 1989
Ishida-Yamamoto A, Iizuka H: Structural organization of cornified cell envelopes and
alterations in inherited skin disorders. Exp Dermatol 7:1–10, 1998
Ishida-Yamamoto A, Hohl D, Roop DR, Iizuka H, Eady RAJ: Loricrin immunoreactivity
in human skin: localization to specific granules (L-granules) in acrosyringia. Arch
Dermatol Res 285:491–498, 1993
Ishida-Yamamoto A, Eady RAJ, Watt FM, Roop DR, Hohl D, Iizuka H: Immunoelectron
microscopic analysis of cornified cell envelope formation in normal and psoriatic
epidermis. J Histochem Cytochem 44:167–175, 1996
Ishida-Yamamoto A, McGrath JA, Lam H, Iizuka H, Friedman RA, Christiano AM: The
molecular pathology of progressive symmetric erythrokeratoderma: a frameshift
mutation in the loricrin gene and perturbations in the cornified cell envelope. Am
J Hum Genet 61:581–589, 1997
Ishida-Yamamoto A, Takahashi H, Iizuka H: Loricrin and human skin disease: molecular
basis of loricrin kratodermas. Histol Histopath 13:819–826, 1998a
Ishida-Yamamoto A, Takahashi H, Presland RB, Dale BA, Iizuka H: Translocation of
profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in
normal human skin and loricrin keratoderma. Lab Invest 78:1245–1253, 1998b
Ishida-Yamamoto A, Tanaka H, Nakane H, Takahashi H, Iizuka H: Inherited disorders of
epidermal keratinization. J Dermatol Sci 18:139–154, 1998c
Kam E, Resing KA, Lim SK, Dale BA: Identification of rat epidermal profilaggrin
phosphatase as a member of the protein phosphatase 2A family. J Cell Sci 106:219–
226, 1993
Kawada A, Hara K, Hiruma M, Noguchi H, Ishibashi A: Rat epidermal cathepsin L-like
proteinase: purification and some hydrolytic properties toward filaggrin and synthetic
substrates. J Biochem 118:332–337, 1995a
Kawada A, Hara K, Morimoto K, Hiruma M, Ishibashi A: Rat epidermal cathepsin B.
purification and characterization of proteolytic properties toward filaggrin and
synthetic substrates. Int J Biochem Cell Biol 27:175–183, 1995b
Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-
ranging implications in tissue kinetics. Br J Cancer 26:239–257, 1972
Korge BP, Ishida-Yamamoto A, Pu¨nter C, Dopping-Hepenstal P, Iizuka H, Stephenson
A, Munro CS: Loricrin mutation in Vohwinkel’s keratoderma is unique to the
variant with ichthyosis. J Invest Dermatol 109:604–610, 1997
Krajewska M, Wang H-G, Krajewski S, Zapata JM, Shabaik A, Gascoyne R, Reed JC:
Immunohistochemical analysis of in vivo patterns of expression of CPP 32 (caspase-3),
a cell death protease. Cancer Res 57:1605–1613, 1997
Krajewski S, Krajewska M, Reed JC: Immunohistochemical analysis of in vivo patterns of
Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res
56:2849–2855, 1996
Mack JW, Steven AC, Steinert PM: The mechanism of interaction of filaggrin with
intermediate filaments. The ionic zipper hypothesis. J Mol Biol 232:50–66, 1993
Maestrini E, Monaco AP, McGrath JA, et al: A molecular defect in loricrin, the major
component of the cornified cell envelope, underlies Vohwinkel’s syndrome. Nature
Genet 13:70–77, 1996
Manabe M, Mizoguchi M, Suto H, Ogawa H: Epidermal structural proteins in skin
disorders. J Dermatol Sci 15:143–165, 1997
Markova NG, Marekov LN, Chipev CC, Gan S-Q, Idler WW, Steinert PM: Profilaggrin
is a major epidermal calcium-binding protein. Mol Cell Biol 13:613–625, 1993
Marthinuss J, Lawrence L, Seiberg M: Apoptosis in Pam212, an epidermal keratinocyte
cell line: a possible role for bcl-2 in epidermal differentiation. Cell Growth Differ
6:239–250, 1995
McCall CA, Cohen JJ: Programmed cell death in terminally differentiating keratinocytes:
role of endogeneous endonuclease. J Invest Dermatol 97:111–114, 1991
Mehrel T, Hohl D, Rothnagel JA, et al: Identification of a major keratinocyte cell envelope
protein, loricrin. Cell 61:1103–1112, 1990
Nicholson DW, Thornberry NA: Caspases: killer proteases. TIBS 22:299–306, 1997
Polakowska RR, Piacentini M, Bartlett R, Goldsmith LA, Haake AR: Apoptosis in human
skin development: morphogenesis, periderm, and stem cells. Dev Dynam 199:
176–188, 1994
Presland RB, Haydock PV, Fleckman P, Nirunsuksiri W, Dale BA: Characterization of
the human epidermal profilaggrin gene. Genomic organization and identification of
an S-100-like calcium binding domain at the amino terminus. J Biol Chem 267:
23772–23781, 1992
Presland RB, Bassuk JA, Kimball JR, Dale BA: Characterization of two distinct calcium-
binding sites in the amino-terminus of human profilaggrin. J Invest Dermatol 104:
218–223, 1995
Presland RB, Kimball JR, Kautsky MB, Lewis SP, Lo CY, Dale BA: Evidence for specific
proteolytic cleavage of the N-terminal domain of human profilaggrin during
epidermal differentiation. J Invest Dermatol 108:170–178, 1997
Resing KA, Walsh KA, Haugen-Scofield J, Dale BA: Identification of proteolytic cleavage
sites in the conversion of profilaggrin to filaggrin in mammalian epidermis. J Biol
Chem 264:1837–1845, 1989
Resing KA, Al Alawi N, Blomquist C, Fleckman P, Dale BA: Independent regulation of
two cytoplasmic processing stages of the intermediate filament-associated protein
filaggrin and role of Ca21 in the second stage. J Biol Chem 268:25139–25145, 1993
Resing KA, Johnson RS, Walsh KA: Mass spectrometric analysis of 21 phosphorylation
sites in the internal repeat of rat profilaggrin, precursor of an intermediate filament
associated protein. Biochem 34:9477–9478, 1995a
Resing KA, Thulin C, Whiting K, Al-Alawi N, Mostad S: Characterization of profilaggrin
endoproteinase 1. A regulated cytoplasmic endoproteinase of epidermis. J Biol Chem
270:28193–28198, 1995b
Roop D: Defects in the barrier. Science 267:474–475, 1995
Rosenthal DS, Simbulan-Rosenthal CMG, Iyer S, Spoonde A, Smith W, Ray R, Smulson
ME: Sulfur mustard induces markers of terminal differentiation and apoptosis in
keratinocytes via a Ca21-calmodulin and caspase-dependent pathway. J Invest Dermatol
111:64–71, 1998
Ruoslahti E, Reed JC: Anchorage dependence, integrins, and apoptosis. Cell 77:
477–478, 1994
Scott IR, Harding CR, Barrett JG: Histidine-rich protein of the keratohyalin granules.
Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the
stratum corneum. Biochim Biophys Acta 719:110–117, 1982
Senshu T, Kan S, Ogawa H, Manabe M, Asaga H: Preferential deimination of keratin K1
and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys
Res Comm 225:712–719, 1996
VOL. 4, NO. 2 SEPTEMBER 1999 CELL DEATH AND LORICRIN KERATODERMA 149
Steigleder GK, Raab WP: The localization of ribonuclease and deoxyribonuclease activities
in normal and psoriatic epidermis. J Invest Dermatol 38:209–214, 1962
Steinert PM, Marekov LN: The proteins elafin, filaggrin, keratin intermediate filaments,
loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked
components of the human epidermal cornified cell envelope. J Biol Chem 270:
17702–17711, 1995
Steller H: Mechanisms and genes of cellular suicide. Science 267:1445–1449, 1995
Steven AC, Bisher ME, Roop DR, Steinert PM: Biosynthetic pathways of filaggrin and
loricrin – two major proteins expressed by terminally differentiated epidermal
keratinocytes. J Struct Biol 104:150–162, 1990
Takahashi M, Tezuka T, Katsunuma N: Filaggrin linker segment peptide and cystatin α
are parts of a complex of the cornified envelope of epidermis. Arch Biochem Biophys
329:123–126, 1996
Takahashi H, Kinouchi M, Iizuka H: Interleukin-1β-converting enzyme and CPP 32 are
involved in ultraviolet B-induced apoptosis of SV40-transformed human
keratinocytes. Biochem Biophys Res Comm 236:194–198, 1997
Takahashi T, Ogo M, Hibino T: Partial purification and characterization of two distinct
types of caspases from human epidermis. J Invest Dermatol 111:367–372, 1998
Takahashi H, Ishida-Yamamoto A, Kishi A, Ohara K, Iizuka H: Loricrin gene mutation
in a Japanese patient of Vohwinkel’s syndrome. J Dermatol Sci 19:44–47, 1999
Watt FM, Hertle MD. Keratinocyte integrins. In: Leigh I, Lane B, Watt F (eds). The
Keratinocyte Handbook. Cambridge: Cambridge University Press, 1994, pp. 153–164
Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev
Cytology 68:251–306, 1980
Yamazaki M, Ishidoh K, Suga Y, et al: Cytoplasmic processing of human profilaggrin by
active µ-calpain. Biochem Biophys Res Comm 235:652–656, 1997
Yoneda K, Hohl D, McBride OW, Wang M, Cehrs KU, Idler WW, Steinert PM: The
human loricrin gene. J Biol Chem 267:18060–18066, 1992
